Skip to content
Radio Logo
Open app
PodcastsLife SciencesPharmaceutical Executive
Listen to this podcast for free in the app:
Pharmaceutical Executive
radio.net
Sleep timer
Save favourites
Download for free in the App Store

Pharmaceutical Executive

Pharmaceutical Executive Podcast
Life SciencesScience
Pharmaceutical Executive
Latest episode

407 episodes

  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: FDA Approves Simtriyo

    2026/07/27 | 3 mins.
    In today's Pharmaceutical Executive Daily, FDA approves Otsuka's Simtriyo as the first NDSRI treatment for ADHD, argenx agrees to acquire Forte Biosciences for approximately $2.2 billion, and an AbbVie neuroscience researcher discusses the shift from symptom management to disease modification in Parkinson's research.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides

    2026/07/24 | 3 mins.
    In today's Pharmaceutical Executive Daily, an FDA advisory panel narrowly votes to recommend easing restrictions on four unapproved peptides, a supply chain expert discusses how China's export controls are exposing vulnerabilities in the U.S. pharmaceutical supply chain, and a pharmacy benefits executive lays out a business case for more targeted employer-based GLP-1 coverage.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Eli Lilly Reports Positive Results from Two Phase III Trials

    2026/07/23 | 3 mins.
    In today's Pharmaceutical Executive Daily, Eli Lilly's Retatrutide delivers up to 22.6% weight loss in two new Phase III trials, a clinical trial expert discusses why the U.S. is losing trial volume to Australia and China, and a pharmacy benefits executive weighs in on why short-term cost thinking is complicating GLP-1 coverage decisions.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Novo Nordisk Files Lawsuit Against Eli Lilly

    2026/07/22 | 2 mins.
    In today's Pharmaceutical Executive Daily, Novo Nordisk sues Eli Lilly over GLP-1 advertising it calls misleading, President Trump announces a phased tariff plan for imported generic drugs, and a new commentary argues pharma's AI investment is missing the areas of drug discovery where it matters most.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: FDA Grants Emergency Use Authorization to Allplex Assay

    2026/07/21 | 3 mins.
    In today's Pharmaceutical Executive Daily, FDA grants emergency use authorization for Seegene's multiplex PCR assay, a Pfizer medical lead makes the case for continued antiviral use among Covid-19 high-risk patients, and Nuvation Bio's CEO discusses the company's oncology pipeline and philosophy of developing better drugs rather than more of them.
More Life Sciences podcasts
Trending Life Sciences podcasts
About Pharmaceutical Executive
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 
Podcast website
Life SciencesScience

Listen to Pharmaceutical Executive, DNA Today: A Genetics Podcast and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Open app
Company
Legal
Service
Apps
Social
South Africa
v8.11.10 | © 2007-2026 radio.de GmbH
Generated: 7/28/2026 - 6:19:54 AM
A company fromMADSACK